Verbascoside: comprehensive review of a phenylethanoid macromolecule and its journey from nature to bench
- 20 August 2024
- journal article
- research article
- Published by Springer Nature in Inflammopharmacology
- Vol. 32 (5) , 2729-2751
Abstract
Polyphenolic compounds are among the most widely researched compounds for various therapeutic applications. However, naturally occurring phenylethanoid glycosides are least explored under this class of compounds. One such phenylethanoid glycoside, verbascoside (Vb), abundantly found among 200 species of 23 families, has gained recent attention due to its wide-spectrum therapeutic properties such as antioxidant, antimicrobial, anti-inflammatory, neuroprotective, cardioprotective, skin-protective, and anti-cancer. Despite having multiple therapeutic benefits, due to its large size, the compound has poor bioavailability for oral and topical applications. To meet these limitations, current research on Vb focuses on delivering it through nanoformulations. Presently, most developed formulations are liposome based for various applications, such as corneal epithelial wound healing, anti-neuropathic, anti-wrinkle, anti-hyperalgesia, atopic dermatitis, alopecia, and cutaneous wound healing. Multiple studies have confirmed the least acute and sub-acute toxicity for Vb. Few clinical studies have been performed for the therapeutic application of Vb to manage COVID-19, nephropathy, platelet aggregation, chronic primary glomerulonephritis, and acute hepatitis. Recent studies have shown the immense therapeutic potential of Vb in wound healing, dermatitis, neuroprotection, and anti-cancer activities, which creates a need for developing novel formulations for their respective uses. Long-term toxicity studies and techniques for scaling up Vb production by biotechnological approaches should be emphasized. Graphical abstractKeywords
Funding Information
- DST SERB-EMEQ (EEQ/2021/000850)
This publication has 191 references indexed in Scilit:
- Vascular protection by dietary polyphenolsEuropean Journal of Pharmacology, 2004
- Inhibiting Activities of the Secondary Metabolites ofPhlomis brunneogaleataagainst Parasitic Protozoa and Plasmodial Enoyl-ACP Reductase, a Crucial Enzyme in Fatty Acid BiosynthesisPlanta Medica, 2004
- Polyphenols: food sources and bioavailabilityThe American Journal of Clinical Nutrition, 2004
- Natural Phenylpropanoids Protect Endothelial Cells Against Oxidized LDL-Induced CytotoxicityPlanta Medica, 2003
- Estimation of carotenoid accessibility from carrots determined by an in vitro digestion methodEuropean Journal of Clinical Nutrition, 2002
- AP-1 in cell proliferation and survivalOncogene, 2001
- Isolation and antibacterial activity of phenylpropanoid derivatives from Ballota nigraJournal of Ethnopharmacology, 1999
- Hepatoprotective Activity of Phenylethanoids fromCistanche deserticolaPlanta Medica, 1998
- Isolation of verbascoside, an antimicrobial constituent of Buddleja globosa leavesJournal of Ethnopharmacology, 1993
- Verbascoside Isolated from Lantana camara, an Inhibitor of Protein Kinase CJournal of Natural Products, 1991